Increased cavernous expression of transforming growth factor-β1 and activation of the smad signaling pathway affects erectile dysfunction in men with spinal cord injury

Journal of Sexual Medicine

Volumn 8, Issue 5, 2011, Pages 1454-1462

  Shin, Tae Young ^a   Ryu, Ji Kan ^a   Jin, Hai Rong ^a   Piao, Shuguang ^a   Tumurbaatar, Munkhbayar ^a   Yin, Guo Nan ^a   Shin, Sun Hwa ^a   Kwon, Mi Hye ^a   Song, Kang Moon ^a   Fang, Zheng Huan ^a   Han, Jee Young ^a   Kim, Woo Jean ^a   Suh, Jun Kyu ^a  

^a Inha University School of Medicine   (South Korea)

Author keywords

Erectile Dysfunction; Fibrosis; Smad; Spinal Cord Injury; Transforming Growth Factor Beta

Indexed keywords

COLLAGEN; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DNA NUCLEOTIDYLEXOTRANSFERASE; PROTEIN ANTIBODY; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CORPUS CAVERNOSUM; ENDOTHELIUM CELL; ERECTILE DYSFUNCTION; FIBROBLAST; HUMAN; IMMUNOREACTIVITY; INFORMED CONSENT; INSTITUTIONAL REVIEW; MALE; NICK END LABELING; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SPINAL CORD INJURY; STAINING; UPREGULATION;

EID: 79955133447     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.02049.x     Document Type: Article

References (41)

1. Wyndaele M, Wyndaele JJ. Incidence, prevalence, and epidemiology of spinal cord injury: What learns a worldwide literature survey. Spinal Cord 2006;44:523-9.
2. Fisher TL, Laud PW, Byfield MG, Brown TT, Hayat MJ, Fiedler IG. Sexual health after spinal cord injury: A longitudinal study. Arch Phys Med Rehabil 2002;83:1043-51.
3. Biering-Sorensen F, Sonksen J. Sexual function in spinal cord lesioned men. Spinal Cord 2001;39:455-70.
4. Stone AR. The sexual needs of the injured spinal cord patient. Probl Urol 1987;1:529-36.
5. Buss A, Pech K, Kakulas BA, Martin D, Schoenen J, Noth J, Brook GA. TGF-beta1 and TGF-beta2 expression after traumatic human spinal cord injury. Spinal Cord 2008;46:364-71.
6. Wang X, Chen W, Liu W, Wu J, Shao Y, Zhang X. The role of thrombospondin-1 and transforming growth factor-beta after spinal cord injury in the rat. J Clin Neurosci 2009;16:818-21.
7. Parekh A, Long RA, Iannone EC, Chancellor MB, Sacks MS. Assessing the effects of transforming growth factor-beta1 on bladder smooth muscle cell phenotype. I. Modulation of in vitro contractility. J Urol 2009;182:1210-5.
8. Nagatomi J, DeMiguel F, Torimoto K, Chancellor MB, Getzenberg RH, Sacks MS. Early molecular-level changes in rat bladder wall tissue following spinal cord injury. Biochem Biophys Res Commun 2005;334:1159-64.
9. Bägli DJ, Joyner BD, Mahoney SR, McCulloch L. The hyaluronic acid receptor RHAMM is induced by stretch injury of rat bladder in vivo and influences smooth muscle cell contraction in vitro. J Urol 1999;162:832-40.
10. Chaqour B, Whitbeck C, Han JS, Macarak E, Horan P, Chichester P, Levin R. Cyr61 and CTGF are molecular markers of bladder wall remodeling after outlet obstruction. Am J Physiol Endocrinol Metab 2002;283:E765-74.
11. Leungwattanakij S, Bivalacqua TJ, Usta MF, Yang DY, Hyun JS, Champion HC, Abdel-Mageed AB, Hellstrom WJ. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 2003;24:239-45.
12. Hu WL, Hu LQ, Li SW, Zheng XM, Tian BC. Expression of transforming growth factor-beta1 in penile tissue from rats with bilateral cavernosal nerve ablation. BJU Int 2004;94:424-8.
13. Fandel TM, Bella AJ, Lin G, Tantiwongse K, Lin CS, Pohl J, Lue TF. Intracavernous growth differentiation factor-5 therapy enhances the recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med 2008;5:1866-75.
14. Canguven O, Lagoda G, Sezen SF, Burnett AL. Losartan preserves erectile function after bilateral cavernous nerve injury via antifibrotic mechanisms in male rats. J Urol 2009;181:2816-22.
15. Zhang LW, Piao S, Choi MJ, Shin HY, Jin HR, Kim WJ, Song SU, Han JY, Park SH, Mamura M, Kim SJ, Ryu JK, Suh JK. Role of increased penile expression of transforming growth factor-beta1 and activation of the Smad signaling pathway in erectile dysfunction in streptozotocin-induced diabetic rats. J Sex Med 2008;5:2318-29.
16. El-Sakka AI, Hassoba HM, Pillarisetty RJ, Dahiya R, Lue TF. Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression. J Urol 1997;158:1391-4.
17. Piao S, Choi MJ, Tumurbaatar M, Kim WJ, Jin HR, Shin SH, Tuvshintur B, Yin GN, Song JS, Kwon MH, Lee SJ, Han JY, Kim SJ, Ryu JK, Suh JK. Transforming growth factor (TGF)-beta type i receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-beta1 responses in fibroblasts derived from Peyronie's plaque. J Sex Med 2010. Mar 11 [Epub ahead of print] doi: 10.1111/j.1743-6109.2010.01753.x.
18. Moreland RB, Watkins MT, Nehera A, Huang YH, Munarriz R, Salimpour P, Goldstein I, Traish AM. Oxygen tension modulates transforming growth factor-beta1 expression and PGE production in human corpus cavernosum smooth muscle cells. Mol Urol 1998;2:41-7.
19. Moreland RB. Is there a role of hypoxemia in penile fibrosis: A viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 1998;10:113-20.
20. Schmid DM, Hauri D, Schurch B. Nocturnal penile tumescence and rigidity (NPTR) findings in spinal cord injured men with erectile dysfunction. Int J Impot Res 2004;16:433-40.
21. User HM, Hairstone JH, Zelner DJ, McKenna KE, McVary KT. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 2003;169:1175-9.
22. Massague J, Chen YG. Controlling TGF-beta signaling. Genes Dev 2000;14:627-44.
23. Isono M, Chen S, Won HS, Carmen Iglesias-De La Cruz MC, Ziyadeh F. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells. Biochem Biophys Res Commun 2002;296:1356-65.
24. Hong SW, Isono M, Chen S, Iglesias-De La Cruz MC, Han DC, Ziyadeh FN. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am J Pathol 2001;158:1653-63.
25. Fujimoto M, Maezawa Y, Yokote K, Joh K, Kobayashi K, Kawamura H, Nishimura M, Roberts AB, Saito Y, Mori S. Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy. Biochem Biophys Res Commun 2003;305:1002-7.
26. Lysiak JJ, Yang SK, Klausner AP, Son H, Tuttle JB, Steers WD. Tadalafil increases Akt and extracellular signal-regulated kinase 1/2 activation, and prevents apoptotic cell death in the penis following denervation. J Urol 2008;179:779-85.
27. Redondo S, Ruiz E, Santos-Gallego CG, Padilla E, Tejerina T. Pioglitazone induces vascular smooth muscle cell apoptosis through a peroxisome proliferator-activated receptor-gamma, transforming growth factor-beta1, and a Smad2-dependent mechanism. Diabetes 2005;54:811-7.
28. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 2002;21:1743-53.
29. Watabe T, Nishihara A, Mishima K, Yamashita J, Shimizu K, Miyazawa K, Nishikawa S, Miyazono K. TGF-beta receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells. J Cell Biol 2003;163:1303-11.
30. Castañares C, Redondo-Horcajo M, Magán-Marchal N, ten Dijke P, Lamas S, Rodríguez-Pascual F. Signaling by ALK5 mediates TGF-beta-induced ET-1 expression in endothelial cells: A role for migration and proliferation. J Cell Sci 2007;120:1256-66.
31. Traish AM, Kim N. Weapons of penile smooth muscle destruction: Androgen deficiency promotes accumulation of adipocytes in the corpus cavernosum. Aging Male 2005;8:141-6.
32. Traish AM, Abu-Zahra H, Guay AT. The brain, the penis and steroid hormones: Clinical correlates with endothelial dysfunction. Curr Pharm Des 2008;14:3723-36.
33. Tsitouras PD, Zhong YG, Spungen AM, Bauman WA. Serum testosterone and growth hormone/insulin-like growth factor-I in adults with spinal cord injury. Horm Metab Res 1995;27:287-92.
34. Celik B, Sahin A, Caglar N, Erhan B, Gunduz B, Gultekin O, Karabulut M. Sex hormone levels and functional outcomes: A controlled study of patients with spinal cord injury compared with healthy subjects. Am J Phys Med Rehabil 2007;86:784-90.
35. Kostovski E, Iversen PO, Birkeland K, Torjesen PA, Hjeltnes N. Decreased levels of testosterone and gonadotrophins in men with long-standing tetraplegia. Spinal Cord 2008;46:559-64.
36. Moreland RB, Traish AM, McMillin MA, Smith B, Goldstein I, Saenz de Tejada I. PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta1 in human corpus cavernosum smooth muscle. J Urol 1995;153:826-34.
37. Ryu JK, Han JY, Chu YC, Song SU, Lee KH, Yoon SM, Suh JK, Kim SJ. Expression of cavernous transforming growth factor-beta1 and its type II receptor in patients with erectile dysfunction. Int J Androl 2004;27:42-9.
38. Grygielko ET, Martin WM, Tweed C, Thornton P, Harling J, Brooks DP, Laping NJ. Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis. J Pharmacol Exp Ther 2005;313:943-51.
39. Bonniaud P, Margetts PJ, Kolb M, Schroeder JA, Kapoun AM, Damm D, Murphy A, Chakravarty S, Dugar S, Higgins L, Protter AA, Gauldie J. Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am J Respir Crit Care Med 2005;171:889-98.
40. de Gouville AC, Boullay V, Krysa G, Pilot J, Brusq JM, Loriolle F, Gauthier JM, Papworth SA, Laroze A, Gellibert F, Huet S. Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis. Br J Pharmacol 2005;145:166-77.
41. Ryu JK, Piao S, Shin HY, Choi MJ, Zhang LW, Jin HR, Kim WJ, Han JY, Hong SS, Park SH, Lee SJ, Kim IH, Lee CR, Kim DK, Mamura M, Kim SJ, Suh JK. IN-1130, a novel transforming growth factor-beta type I receptor kinase (activin receptor-like kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie's disease. J Sex Med 2009;6:1284-96.